Shandong Weigao boosts treasury holdings with latest share repurchase

Shandong Weigao Group Medical Polymer Company Limited, a listed issuer on the Hong Kong Stock Exchange, repurchased 360,000 ordinary H shares on November 14, 2025. The buyback was executed on the Exchange at prices ranging from HK$5.47 to HK$5.5 per share, with an aggregate cost of HK$1,976,000. These repurchased shares will be held as treasury shares, increasing the company's treasury holdings to 24,870,000 shares.

This transaction resulted in a 0.008% reduction in the number of issued shares (excluding treasury shares), bringing the total to 4,497,462,324. The total number of issued shares remains unchanged at 4,522,332,324. The repurchase was conducted under a mandate granted on May 27, 2025, which authorized the company to repurchase up to 451,560,392 shares.

Following this latest repurchase, the company has now repurchased a total of 18,221,600 shares under the current mandate, representing 4.0353% of the issued shares (excluding treasury shares) as of the mandate date. A moratorium period for new share issues or sales of treasury shares is in effect until December 13, 2025.